Key Takeaways
- Piper Sandler launched coverage of Rocket Lab (RKLB) with a Neutral stance and set a price target of $83
- Shares are currently hovering between $66 and $76, reflecting a steep decline, with concerns about elevated valuation versus Fair Value
- On July 7, CEO Peter Beck offloaded 1.3 million shares at $84.92 each through a pre-established 10b5-1 trading plan
- Most recent quarter showed revenue climbing 63.4% compared to last year, reaching $200.35 million and surpassing forecasts
- Morgan Stanley maintains an Overweight position with a $105 target; average analyst consensus stands at $110.18
Rocket Lab (RKLB) is experiencing significant turbulence this week. Shares have plunged approximately 13%, now changing hands near $66—a considerable distance from the 12-month peak of $151.
On Wednesday, Piper Sandler launched its coverage of the aerospace company with a Neutral rating alongside an $83 price objective. The firm arrived at this valuation using a multiple of 39 times enterprise value to revenue for fiscal year 2027.
Rocket Lab’s market capitalization currently ranges between $41.5 billion and $44 billion. According to InvestingPro, the shares appear overvalued when measured against Fair Value metrics, sporting a Price/Book multiple of 18.88.
The company commands a higher valuation multiple than SpaceX when comparing enterprise value to revenue. Piper Sandler anticipates this valuation dynamic will persist throughout the next twelve months.
Nonetheless, RKLB has generated a 59.78% gain over the trailing year while expanding revenue by 45.83% during the same timeframe. The business is clearly accelerating.
Impressive Results, Yet Uncertainty Lingers
The latest quarterly performance was robust. First-quarter revenue reached $200.35 million, representing a 63.4% year-over-year surge and exceeding Wall Street’s projection of $189.65 million.
Earnings per share landed at -$0.07, aligning with expectations. Analysts are forecasting full-year EPS of -$0.26.
The organization successfully conducted a complete-duration test of the Neutron engine, representing a critical checkpoint ahead of the larger rocket’s maiden flight. This achievement garnered positive attention.
Rocket Lab also recently finalized an $8 billion acquisition of Iridium Communications. Following this announcement, Morgan Stanley reaffirmed its Overweight recommendation with a $105 price objective.
Cantor Fitzgerald likewise maintained its Overweight view after the successful U.S. Space Force VICTUS HAZE mission, establishing a $96 price target.
Executive Stock Sales Draw Attention
CEO Peter Beck divested 1,298,622 shares on July 7 at an average transaction price of $84.92, generating proceeds exceeding $110 million. This sale was executed through a pre-established Rule 10b5-1 trading arrangement.
Following the transaction, Beck retains ownership of 2,715,181 shares with an approximate value of $230 million.
Collectively, company insiders have disposed of 3,849,294 shares valued at roughly $362.8 million during the previous three months. Each transaction occurred under 10b5-1 plans.
Calamos Advisors dramatically reduced its RKLB holdings by 90.1% during the first quarter, scaling back from 245,980 to just 24,393 shares worth approximately $1.57 million.
Institutional investors continue to control 71.78% of outstanding shares.
The stock’s 50-day moving average currently sits at $108.95, while the 200-day moving average stands at $87.31. RKLB is trading substantially beneath both technical indicators.
Wall Street’s consensus rating is Moderate Buy with an average price objective of $110.18. Wells Fargo holds the most cautious outlook at $60, whereas New Street Research rates the stock a Buy with a $150 target.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
